Healthcare provider profile · identity verified

Aleksandr Shpigel, M.D.

Internal Medicine · PHILADELPHIA, PA · NPI 1942234158

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	866	256
Amlodipine Besylate	Amlodipine Besylate	579	173
Metformin Hcl	Metformin Hcl	351	95
Omeprazole	Omeprazole	307	92
Hydrochlorothiazide	Hydrochlorothiazide	267	74
Lisinopril	Lisinopril	235	65
Gabapentin	Gabapentin	224	58
Fluticasone Propionate	Fluticasone Propionate	217	90
Losartan Potassium	Losartan Potassium	179	54
Levothyroxine Sodium	Levothyroxine Sodium	172	50
Jardiance	Empagliflozin	166	32
Pantoprazole Sodium	Pantoprazole Sodium	160	48
Alprazolam	Alprazolam	147	25
Tamsulosin Hcl	Tamsulosin Hcl	146	45
Eliquis	Apixaban	143	31
Rosuvastatin Calcium	Rosuvastatin Calcium	142	52
Escitalopram Oxalate	Escitalopram Oxalate	135	35
Zolpidem Tartrate	Zolpidem Tartrate	132	30
Carvedilol	Carvedilol	130	31
Pravastatin Sodium	Pravastatin Sodium	130	30
Furosemide	Furosemide	128	35
Albuterol Sulfate Hfa	Albuterol Sulfate	126	40
Simvastatin	Simvastatin	121	32
Lorazepam	Lorazepam	110	21
Metoprolol Tartrate	Metoprolol Tartrate	108	26
Famotidine	Famotidine	101	32
Nifedipine Er	Nifedipine	99	22
Ramipril	Ramipril	99	24
Allopurinol	Allopurinol	94	32
Metoprolol Succinate	Metoprolol Succinate	94	32
Atenolol	Atenolol	91	22
Ozempic	Semaglutide	89	17
Clonazepam	Clonazepam	82	19
Trazodone Hcl	Trazodone Hcl	82	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	80	13
Montelukast Sodium	Montelukast Sodium	79	20
Alendronate Sodium	Alendronate Sodium	76	19
Ezetimibe	Ezetimibe	75	23
Tramadol Hcl	Tramadol Hcl	75	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	16
Meloxicam	Meloxicam	70	24
Clopidogrel	Clopidogrel Bisulfate	69	19
Ibuprofen	Ibuprofen	68	27
Oxycodone Hcl	Oxycodone Hcl	65	13
Glimepiride	Glimepiride	61	16
Nortriptyline Hcl	Nortriptyline Hcl	57	suppressed
Potassium Chloride	Potassium Chloride	56	15
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	55	11
Donepezil Hcl	Donepezil Hcl	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	19
Synthroid	Levothyroxine Sodium	52	16
Citalopram Hbr	Citalopram Hydrobromide	51	11
Duloxetine Hcl	Duloxetine Hcl	50	12
Diclofenac Sodium	Diclofenac Sodium	49	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Sertraline Hcl	Sertraline Hcl	47	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	11
Pregabalin	Pregabalin	45	12
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Diazepam	Diazepam	40	suppressed
Valacyclovir	Valacyclovir Hcl	40	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	38	suppressed
Azelastine Hcl	Azelastine Hcl	36	12
Baclofen	Baclofen	35	suppressed
Metformin Hcl Er	Metformin Hcl	35	11
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	17
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Eszopiclone	Eszopiclone	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Clonidine	Clonidine	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Glipizide	Glipizide	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Valsartan	Valsartan	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Hydrocortisone	Hydrocortisone	24	15
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	16
Warfarin Sodium	Warfarin Sodium	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	12
Lovastatin	Lovastatin	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Valium	Diazepam	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Balsalazide Disodium	Balsalazide Disodium	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Acetazolamide Er	Acetazolamide	12	suppressed
Acyclovir	Acyclovir	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Prednisone	Prednisone	12	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	11	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Desloratadine	Desloratadine	11	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error